An Bioequivalence Study Of Xanax Extended Release Tablets From Two Different Manufacturing Sites

NCT01330472 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

16

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Subjects

Interventions

DRUG: Xanax XR tablets 3 mg (sourced from Caugus)
DRUG: Xanax XR tablets 3 mg (sourced from Barceloneta)

Sponsor

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.